CD47 and head and neck cancer: conducted macrophage phagocytosis experiments on the HN31R head and neck cancer cell line and found that the downregulation of Tristetraprolin (TTP) can induce sustained overexpression of CD47, which, in turn, inhibits the phagocytosis of head and neck cancer cells (100).